Bayer CropScience Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 5/6
Bayer CropScience has a total shareholder equity of ₹28.5B and total debt of ₹471.0M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are ₹46.0B and ₹17.5B respectively. Bayer CropScience's EBIT is ₹8.0B making its interest coverage ratio -24.6. It has cash and short-term investments of ₹12.1B.
Anahtar bilgiler
1.7%
Borç/özkaynak oranı
₹471.00m
Borç
| Faiz karşılama oranı | -24.6x |
| Nakit | ₹12.11b |
| Eşitlik | ₹28.49b |
| Toplam yükümlülükler | ₹17.48b |
| Toplam varlıklar | ₹45.97b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 506285's short term assets (₹39.1B) exceed its short term liabilities (₹16.0B).
Uzun Vadeli Yükümlülükler: 506285's short term assets (₹39.1B) exceed its long term liabilities (₹1.5B).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 506285 has more cash than its total debt.
Borcun Azaltılması: 506285's debt to equity ratio has increased from 0% to 1.7% over the past 5 years.
Borç Kapsamı: 506285's debt is well covered by operating cash flow (2020.4%).
Faiz Kapsamı: 506285 earns more interest than it pays, so coverage of interest payments is not a concern.